PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a non-blinded, non-randomized pharmacokinetic study to determine the oral
bioavailability of clofarabine, and the effect of cimetidine on clofarabine pharmacokinetics
in patients with poor-risk acute leukemias and myelodysplastic syndrome (MDS).